Johnson & Johnson CFO Joseph Wolk discusses the company's first-quarter earnings, forecast and product pipeline on Bloomberg Television. Johnson & Johnson’s first-quarter drug sales narrowly outpaced Wall Street expectations as the company beat profit estimates.

For more on this story, please see: https://www.bloomberg.com/news/articl...